Contact
Subiton Cements

POWER TO CEMENT AND SECURE

Perfect partner for your prosthesis fixation

Subiton bone cements are manufactured in-house under strictly controlled conditions using our proprietary process. Indicated for use in bone cementation and prosthesis fixation, they provide a tight mechanical fit between the irregular bone surface and the prosthesis. The Subiton bone cement range includes gentamicin-loaded cements for revision procedures in patients at
high risk of infection due to gentamicin-sensitive bacteria and patients with
compromised immunity.1,2

  • High and low viscosities for flexible application and use
  • Gentamicin-loaded options to support cases with high risk of infection
  • Optimum working time and predictable performance
  • Highest standards of quality assurance

High performance fixation in infected and non-infected cases

Developed to provide an ideal interface between prosthesis and bone, Subiton bone cements are optimised to provide secure and stable fixation for joint replacement surgery.

High and low viscosities for flexible application and use

Choice of setting times and consistencies to suit individual applications or cases, allowing for high hold with manual placement or deep placement with a syringe or vacuum mixing application system.

Gentamicin-loaded options to support cases with high risk of infection

Available preloaded with gentamicin to support cases in patients with compromised immunity or revision cases in patients with a high risk of infection.

Optimum working time and predictable performance

Subiton bone cements allow sufficient time to work into position with well characterised ambient temperature-dependent setting profiles.

Highest standards of quality assurance from raw materials to finished product

Committed to the highest international certifications of quality, reliability and efficacy. End-to-end oversight of the design, development and manufacturing processes guarantees the highest quality at every stage.

Subiton Cements products
Subiton RO

Specifically designed with high performance mechanical properties to optimise fixation, whilst distributing and buffering the forces between bone and implant.3

  • Manual application
  • Bone cementation and prosthesis fixation
  • Easy-to-use dough with optimum working time
  • High performance mechanical properties
Subiton G

Bone cement preloaded with gentamicin for when a broad spectrum antibiotic is required.

  • Manual application
  • Indicated for revision procedures and high-risk patients
  • Easy-to-use dough with optimum working time
  • High performance mechanical properties
Subiton GUN

Enables high bone cement penetration into bone to enhance fixation, whilst distributing and buffering the forces between bone and implant.3,4

  • Syringe or vacuum mixing application system
  • Bone cementation and prosthesis fixation
  • Longer working time than high viscosity
  • High bone cement penetration into bone
Subiton GUN G

Bone cement preloaded with gentamicin for when a broad spectrum antibiotic is required.

  • Syringe or vacuum mixing application system
  • Indicated for revision procedures and high risk patients
  • Longer working time than high viscosity
  • High bone cement penetration into bone

References and regulatory statements

1. Subiton surgical cement with gentamicin. Instructions for Use.
2. Subiton surgical cement. Instructions for Use.
3. Breusch, S., Malchau, H., & Kühn, K. D. (2005). What is Bone Cement? The Well-Cemented Total Hip Arthroplasty: Theory and Practice, 52-59.
4. Mjöberg, B., Rydholm, A., Selvik, G., & Önnerfalt, R. (1987). Low-versus high-viscosity bone cement: Fixation of hip prostheses analyzed by roentgen stereophotogrammetry. Acta Orthopaedica Scandinavica, 58(2), 106-108.

©2023, Biocomposites, STIMULAN, genex, Biosteon, Allogran are trademarks/registered trademarks of Biocomposites Ltd. Synimed and Synicem are trademarks/registered trademarks of Synergie Ingénierie Médicale S.A.R.L. All rights reserved. No unauthorised copying, reproduction, distributing, or republication is allowed unless prior written permission is granted by the owner, Biocomposites Ltd.
Patents granted: EP 1390086 B1, US 8632796, CN ZL02809194.9, US 8496955, GB2367552, EP 1204599 B1, US 6780391, EP 1436019 B1, US 8563024, CN ZL02825134.2, EP 2594231 B1, US 8883063, CN ZL201210466117.X, GB2496710, EP 3058899 B1, US 10390954, US 10,588,748, CN ZL201610089710.5
Patents Pending: GB1502655.2, GB1704688.9, EP 18275044.8, US 15/933936, CN 108619579A.

MA0422R1